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Obesity is associated with immunological perturbations that contribute to insulin resistance. Epigenetic mechanisms can control
immune functions and have been linked to metabolic complications, although their contribution to insulin resistance still remains
unclear. In this study, we investigated the link betweenmetabolic dysfunction and immune alterations with the epigenetic signature
in leukocytes in a porcine model of obesity. Global DNAmethylation of circulating leukocytes, adipose tissue leukocyte trafficking,
andmacrophage polarisationwere established by flow cytometry. Adipose tissue inflammation andmetabolic functionwere further
characterised by quantification of metabolites and expression levels of genes associated with obesity and inflammation. Here we
show that obese pigs showed bigger visceral fat pads, higher levels of circulating LDL cholesterol, and impaired glucose tolerance.
These changes coincidedwith impairedmetabolism, sustainedmacrophages infiltration, and increased inflammation in the adipose
tissue.Those immune alterations were linked to global DNAhypermethylation in both B-cells and T-cells. Our results provide novel
insight into the possible contribution of immune cell epigenetics into the immunological disturbances observed in obesity. The
dramatic changes in the transcriptomic and epigenetic signature of circulating lymphocytes reinforce the concept that epigenetic
processes participate in the increased immune cell activation and impaired metabolic functions in obesity.
1. Introduction
Obesity is associatedwith awide range of complications, such
as insulin resistance, type 2 diabetes, fatty liver, cardiovas-
cular diseases, and cancer [1–3]. Abnormal adipose tissue
expansion leads to a chronic low-grade inflammatory state,
due to increased recruitment and infiltration of immune cells
into the tissue [4]. In particular, the number of classically
activated or M1 adipose tissue macrophages (ATMs) is
increased in obesity, and these cells are key contributors to
the proinflammatory environment through the secretion of
cytokines [5, 6]. Both T- and B-cells contribute to the initia-
tion andmaintenance of adipose tissue inflammation and are
responsible for the recruitment of macrophages [7, 8]. Such
proinflammatory environment is an important contributor
to the development of insulin resistance and type 2 diabetes
[9, 10].
Both genetic and environmental factors contribute
to the development of obesity and associated diseases.
The DNA methylome, a molecular mechanism mediating
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the interplay between genetic and environmental factors,
influences metabolic functions by regulating gene expression
in specific cell types [11, 12]. Recent studies have reported the
existence of a specific epigenetic signature in peripheral blood
mononuclear cells (PBMCs) in obese subjects [13] with obese
individuals characterised by a hypermethylation and greater
variation in global DNA methylation than lean subjects [14,
15]. In T-cells, B-cells, and macrophages, epigenetic regula-
tions of genes involved in trafficking and polarised activation
have been reported [16–18] and candidate gene approaches
have identified epigenetic regulations of the TNF𝛼 and Leptin
genes in obesity [19, 20]. Thus, the epigenetic signature of
circulating and infiltrated immune cells could play a signif-
icant role in the inflammatory process observed in obesity.
Pigs share a plethora of similarities with humans in terms
of diet, genetics, and metabolism and are thus pertinent
animal models to study obesity [21, 22]. The significant
similarity in the genome further supports the possibilities to
translate the research findings into humans [22]. In particular
genes regulating immunological functions show preservation
of orthology of more than 80% between pigs and humans,
compared to less than 10% between human and mice [23].
Here, we developed a polygenetic pig model designed for
elucidating molecular components underlying obesity. Our
pigs were bred under controlled conditions (housed in the
same building under the same environmental conditionswith
unrestricted access to food and water) and were monitored
intensively during their lifespan, and diseased pigs were
excluded from the study. Thus, confounding environmental
factors that could potentially influence their epigenetic profile
were limited.
Here, we hypothesised that obesity-related changes in
immune functions are linked to epigenetic mechanisms,
leading to metabolic disorders. Using a novel porcine model
of obesity, we aimed at investigating the link between epi-
genetic changes in immune cells and their impact on immune
cell trafficking and functions, as well as lipid and glucose
metabolism. We show that obesity is characterised by
increased immune cell infiltration in the adipose tissue and
increased expression level of critical genes involved in
immune response and lipid metabolism. Obesity was asso-
ciated with increased global DNAmethylation of subpopula-
tions of immune cells.Wepropose that this specific epigenetic
signature could represent an early marker associated with
immune cell recruitment and activation in obesity.
2. Material and Methods
2.1. Animals. Pigs from two highly divergent breeds, that is,
Duroc and Go¨ttingen minipigs, were bred to generate an
F2 population. To ensure segregation of obesity traits in the
F2 population,we used a breed that has been bred for leanness
for decades (Duroc) and a breed prone to obesity (Go¨ttingen
minipigs) as previously described [24]. All F1 pigs were gen-
erated in the same direction and intercrossed to produce
the F2 progeny. We selected 18 pigs from this F2 progeny
with the most extreme obese and lean phenotypes. The
specific characteristics used for the selection were body
mass index (BMI), abdominal circumference, and amount of
retroperitoneal fat.The sex distributionwas 7males/3 females
in the obese group and 7 males/1 female in the lean group.
All pigs were housed in the same production farm, with
10–15 animals per pen and ad libitum access to standard
production pig feed and water [24]. None of the animals
included in this study received any antibiotics. Animal care,
maintenance, and experimental work were conducted
according to the “Animal Maintenance Act” (Act 432 dated
09/06/2004) and with the approval from the Danish Animal
Experimentation Board (J.nr. 2007/561-1434). The pigs
were slaughtered (9–13 months old, slaughtering weight:
67–160 kg) at a commercial slaughterhouse after overnight
fasting. Weight, length, and abdominal circumference were
measured prior to slaughter and tissue and blood samples
were collected at slaughter. The animals were euthanized
according to approved procedures under the supervision
of a veterinarian (electronic stunning and bleeding). The
following visceral fat samples were collected and weighed:
retroperitoneal fat, greater omentum, and mesenteric fat,
with the latter measured from an 8 cm diameter large section
of the mesenteric fat in the triangle between ileum and
cecum.
2.2. Oral Glucose Tolerance Test (OGTT). Pigs were fasted
for 24 h and challenged with 4mL/kg of a 50% glucose
solution mixed in food as previously described [25]. The
pigs consumed the glucose mix within 30 minutes and
blood glucose levels were measured with a Freestyle Mini
glucometer (Hermedico, Brøndby, Denmark) using a drop of
blood from the ear vein at fasting and every 30 minutes for
three hours after the challenge.
2.3. Plasma Lipids. Plasma lipid profile was established using
an Autoanalyzer (Konelab 20, Thermo Fisher Scientific,
Waltham, MA, USA) and commercial kits from Roche
Diagnostics for total cholesterol (Roche Diagnostics, Basel,
Switzerland) and fromThermo Electron (Thermo Fisher Sci-
entific) for triglycerides (TG) andHDL-cholesterol (HDL-C).
Fasting plasma LDL-C was calculated using the Friedewald
formula [26].
2.4. Cell Isolation
2.4.1. Adipose Tissue Stromal Vascular Fraction (SVF). The
SVF containing preadipocytes and mononuclear cells was
isolated from the retroperitoneal adipose tissue (approx-
imately 15 g) from 12 animals (6 lean and 6 obese) as
previously described [27] with a few modifications. Briefly,
the adipose tissue was quickly removed from the animal after
slaughter and rinsed in 37∘C phosphate buffer saline (PBS),
supplemented with 1% Penicillin/Streptomycin solution and
1% bovine serum albumin (BSA).The tissue was minced with
scissors, and 20mL of prewarmed (37∘C) 0.2% collagenase
solution in Hanks’ Balanced Salt Solution and 1% BSA was
subsequently added and then incubated for approximately
90min in a 37∘C water bath. The digested material was
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filtered through a 200 𝜇m sterile nylon filter and washed with
Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% FBS
and 4.5 g/L glucose, and the mature adipocytes were allowed
to float.Thepellet containing the preadipocytes andmononu-
clear cells was filtered through a 40 𝜇m nylon filter, followed
by centrifugation for 10min at 400×g. The supernatant was
removed and the pellet was washed twice in DMEM and
subsequently preserved in aliquots of approximately 1 × 106
cells per vial in DMEM (45% FBS and 10% DMSO) by
gradually decreasing the temperature by 1∘C/min to −80∘C
and then kept in liquid nitrogen until further analysis.
2.4.2. Peripheral Blood Mononuclear Cells. The PBMCs were
isolated from 2 × 6mL of blood using Lymphoprep (Progen,
Heidelberg, Germany) and washed in RMPI-1640 (25mM
HEPES). The purified PBMCs were resuspended in autol-
ogous plasma and preserved in aliquots of approximately
5 × 106 cells per vial in 40% RPMI-1640 (10% DMSO) by
gradually decreasing the temperature by 1∘C/min to −80∘C
and then transferred to liquid nitrogen until further analysis.
2.5. Flow Cytometry
2.5.1. Surface Staining of SVF Cells. SVF cells (1 × 106)
were quickly thawed at 37∘C, washed once in RPMI-1640,
resuspended in PBS (1% BSA), and incubated with the
following antibodies: CD3𝜀-PerCp5.5, CD4-PE, and CD8𝛼-
Alexa Fluor 647 (all from BD, New Jersey, USA), CD21-APC
and CD203a-DyLight405 (both from Novus Biologicals,
Littleton, CO, USA), CD11R3-FITC (AbD serotec, Puchheim,
Germany), CD45-DyLight680 (LSBio, Seattle, WA, USA),
CD163-Alexa Fluor 350 and NKp46-PE (both from Bioss
Antibodies, Woburn, MA, USA), for 20min at RT in the
dark, washed once with PBS (1% BSA) and fixed in 1% PFA
for immediate analysis on a LSRFortessa flow cytometer
(BD) at the Biological Resources Imaging Laboratory (Flow
Cytometry Facility, UNSW Australia, Australia). T-cells
were defined as CD45+CD3+. Within the T-cells, T-helper
cells were defined as CD45+CD3+CD4+, T-cytotoxic
cells as CD45+CD3+CD8+, and double positive T-cells as
CD45+CD3+CD4+CD8+. Macrophages were defined as
CD45+CD3−CD203A+, and the M1 and M2 macrophages
were determined based on positivity for CD11R3
(CD45+CD3−CD203A+CD11R3+) and CD163, respectively
(CD45+CD3−CD203A+CD163+). B-cells were
CD45+CD3−CD203A−CD21+ whereas NK-cells were
CD45+CD3−CD203A−NKp46+.
2.5.2. Surface Staining of PBMCs. PBMCs (5 × 106 cells) were
quickly thawed at 37∘C, washed once in RPMI-1640, and
resuspended in PBS (1% BSA). They were then incubated
with the following antibodies: CD3𝜀-PerCp5.5, CD4-PE, and
CD8𝛼-Alexa Fluor 647 orCD3𝜀-PerCp5.5, NKp46-PE, CD21-
APC, andmonocyte/granulocytemarker-PE (BD), for 20min
at room temperature. Cells were then washed twice with PBS
(1%BSA) andfixed in 300𝜇LPBS 1%PFA for immediate anal-
ysis using a FACSCalibur flow cytometer (BD). Lymphocytes
and monocytes were defined based on size and granularity as
well as the monocytes/granulocytes marker. T-cells, B-cells,
and NK-cells were defined as described above, except for the
omission of CD203A staining.
2.5.3. DNA Methylation in PBMCs. Global DNA methyla-
tion in PBMCs was measured as previously described [14]
with a few modifications. Briefly, PBMCs (10 × 106 cells)
were quickly thawed at 37∘C, washed twice in RPMI-1640,
resuspended in PBS (1% BSA), and incubated with CD4-
PE and CD8𝛼-Alexa Fluor 647 for 20min at room tem-
perature. Cells were then fixed in 2% PFA for 10min at
37∘C and permeabilised in 90% methanol for 30min at
−20∘C. After three washes in PBS (1% BSA and 0.1% Tween-
20), DNA was denaturated by adding 2N HCl for 30min
(37∘C) and cells were subsequently incubated in 0.1M borate
buffer for 5min and washed three times again. PBMCs
were finally resuspended in PBS (1% BSA, 0.1% Tween-20)
and the following antibodies, CD3𝜀-PerCp5.5, CD21-APC
(BD) and monocyte/granulocyte-PE, and 5-methylcytidine-
DyLight488 (Novus Biologicals), were added for an incu-
bation period of 20min at room temperature in the dark.
After two washes, cells were fixed in 1% PFA and immediately
acquired on a FACSCalibur (BD).
2.6. Analysis of Flow Cytometry Data. All the FACS data were
analysed using FlowJo software v10.0.7 (Ashland, OR, USA)
and normalized using isotype controls. For the acquisition on
the FACSCalibur, compensations were performed on single
stained control samples before acquisition. Data collected on
LSRFortessawas analysedwith post-compensation onFlowJo
using compensation beads fromBeckmanCoulter (Brea, CA,
USA).
2.7. Total RNA Isolation and High-Throughput QPCR. Total
RNA was purified from retroperitoneal adipose tissue from
all 18 animals as previously described [28]. PBMCs (10 × 106
cells) were quickly thawed at 37∘C, washed once in RPMI-
1640, and then resuspended in 1mL of TriReagent (Molec-
ular Research Center, Cincinnati, OH, USA). Total RNA
was then purified [28] with the omission of the additional
centrifugation step to remove lipids. RNA concentration was
estimated using a NanoDrop 1000 (Thermo Fisher Scientific)
and the quality was assessed on an Experion system (Bio-Rad,
Hercules, CA, USA), with all RQI values between 7.8 and 9.9.
cDNA synthesis was performed on 400 ng in duplicate using
Improm-IITM reverse transcriptase (Promega,Madison,WI,
USA) and a 3 : 1 mixture of random hexamers/OligodT,
according to the manufacturer’s recommendations. cDNA
was diluted 1/16 prior to the QPCR.
QPCRwas performed on the BiomarkHD96.96 IFC chip
(Fluidigm Corporation, San Francisco, CA, USA) according
to the manufacturer’s protocol and data collected using the
associated software. Raw Cq values were subsequently trans-
ferred to Genex5 Pro (MultiD, Go¨teborg, Sweden), and the
relative expression levels of the tested genes were normalised
to RPL4, as this gene showed the highest stability in both
adipose tissue and PBMC samples. Technical replicates were
averaged, and data was log transformed to achieve normal
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Figure 1: Anthropometric and metabolic characteristics in the lean group of animals (𝑛 = 8, grey columns and line) and in the obese group
of animals (𝑛 = 10, open columns and a black line). The animals were weighted before slaughter (a), and after slaughter the weight of the
retroperitoneal fat (b), omental fat (c), and mesenteric fat (d) was measured. Triglycerides (TG), high-density lipoprotein (HDL-C), and
low-density lipoprotein (LDL-C) were measured from plasma collected after an overnight fast (e). Oral glucose tolerance test (OGTT) was
performed only on males (7 in each group) after an overnight fast, and blood glucose was measured every 30min for 3 hours (f). Data are
mean ± SD. ∗𝑝 < 0.05 compared to lean. †𝑝 < 0.05 compared to baseline.
distribution. The genes, primer sequences, and normalised
log(2) transformed fold changes (FC) are all listed in Sup-
plementary Table 1 in the Supplementary Material available
online at http://dx.doi.org/10.1155/2016/8539057 .
QPCR of SSP1, SREBF1, IL4, ADIPOR1, and RPL4 was
performed on Mx3005P (Agilent, Santa Clara, CA, USA)
using QuantiFast SYBR Green PCR Master Mix (Qiagen,
Hilden, Germany) according to supplier’s instruction and
analysed in Genex5 Pro as described above.
2.8. Statistical Analysis. Values are expressed as mean ± SD
and statistical analysis was performed on SPSS Statistics
for Mac (Version 22, IBM, USA). Normality of the distri-
bution was tested using the D’Agostino skewness test and
the Anscombe-Glynn kurtosis test. In case of nonnormal
distribution, data was log transformed to achieve normal
distribution. Differences between the two groups were tested
using unpaired Student’s 𝑡-test. Data from the OGTT was
analysed by ANOVA for repeatedmeasures. Statistical signif-
icance was set at 𝑝 < 0.05.
3. Results
3.1. Animal Characteristics. The animals used in this study
were selected from a population designed to exhibit large
variation in obesity traits. The obese group of pigs had
significantly higher body weight and increased mass in the
different fat pads (Figures 1(a)–1(d), 𝑝 < 0.05), whereas both
age (10.4 ± 1.6 versus 9.3 ± 0.7 months) and length (86.4 ±
5.2 versus 90.4 ± 8.5 cm) did not differ significantly. The
measured fat pads, retroperitoneal, omental, and mesenteric,
are all part of the abdominal visceral fat depots, in which
adipocyte sizes and numbers have been highly correlated
withmetabolic diseases.Metabolic perturbationswere clearly
identified in the obese group, as circulating LDL-C levels were
significantly higher (Figure 1(e)). Given that previous reports
showed a sex-specific blood glucose variation in obesity [25],
we only included male pigs in the analysis of the OGTT.
We found no difference in fasting blood glucose but a trend
towards impaired glucose clearance in the obese as compared
to the lean animals (Figure 1(f)).Thus, our data supports that
our model successfully recapitulated the obese phenotype
typically reported in humans.
3.2. Altered Immune Cells Distribution in Both Adipose Tissue
and Circulating Leukocytes. After extraction of the SVF from
the retroperitoneal fat pads, we isolated leukocytes and phe-
notyped them using high-resolution 14-colour flow cytom-
etry. The comparison of lean with obese pigs did not reveal
any difference in the frequency of infiltrated T-cells, although
the percentage of T-helper cells was decreased in obese
animals (Figure 2(d)). The frequency of mature ATMs was
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Figure 2: Phenotypic characterisation by flow cytometry of the adipose SVF cells and PBMCs in lean and obese pigs. (a) Gating strategy of
the porcine adipose SVF cells from an obese pig. T-cells were defined as CD45+CD3+. Within the T-cells, CD4+, CD8+, and CD4+CD8+
were characterised based on positivity for CD4 and CD8. Macrophages were defined as CD45+CD3−CD203A+, and the M1 and M2
macrophages were determined based on positivity for CD11R3 and CD163, respectively. B-cells were CD45+CD3−CD203A− and CD21+
whereas NK-cells were CD45+CD3−CD203A− and NKp46+. (b–d) Infiltrating leukocyte populations in the adipose tissue within the CD45+
population from lean (grey columns) and obese (white columns) pigs. (b) Frequency of the total macrophages (CD203A+), classically
activatedM1macrophages (CD203+CD11R3+), and alternatively activatedM2macrophages (CD203+CD163+). (c) Frequency of natural killer
cells (NKp46+) and B-cells (CD21+). (d) Frequency of the T-helper (CD3+CD4+), T-cytotoxic (CD3+CD8+), and double positive T-cells
(CD3+CD4+CD8+) within the T-cells. (e–g) PBMCs subpopulation frequencies. (e) Lymphocytes and monocytes. (f) Natural killer cells
(CD3−NKp46+) and B-cells (CD3−CD21+) populations frequency. (g) Frequency of the T-helper (CD3+CD4+), T-cytotoxic (CD3+CD8+),
and double positive T-cells (CD3+CD4+CD8+) within the T-cells. Data are mean ± SD. ∗𝑝 < 0.05.
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Figure 3: Expression profile of the genes that showed a log(2) fold change ratio higher than 1.5.The log(2) difference between lean and obese
pigs in the retroperitoneal adipose tissue (a) and the PBMCs (b). +log(2) FC: upregulated in obese pigs; − log(2) FC: downregulated in obese
pigs. Gene names and columns in black: significant differential expression. ∗𝑝 < 0.05.
increased in the obese group (Figure 2(b)) and was further
associated with an increased frequency of M1 macrophages
(Figure 2(b)), whereas no difference was observed for the
frequency of M2 macrophages between the two groups
(Figure 2(b)).
To determine if the proinflammatory phenotype we
observed in the adipose tissuewas linked to systemic immune
changes, we investigated the cell type distribution in circu-
lating PBMCs. Obese animals showed a higher percentage
of B-cells (Figure 2(f)) and a lower frequency of monocytes
(Figure 2(e)).
The increased macrophage infiltration we detected and,
in particular, the proinflammatory macrophages, in conjunc-
tion with the decreased number of peripheral monocytes,
suggests that an active recruitment of monocytes/macro-
phages occurs in the adipose tissue of obese animals.
3.3. Differential Gene Expression in Adipose Tissue and Cir-
culating Leukocytes from Obese Pigs. To investigate gene
expression variation in obesity, we profiled RNA expression
in both retroperitoneal adipose tissue and PBMCs from lean
and obese pigs. In particular, we focused on adipokines,
cytokines, chemokines, and genes known to be actively
involved in obesity and inflammation. Of the 72 genes
investigated, 60 were specific to the adipose tissue and 50 to
the PBMCs. Sixty-six of these revealed a log(2) fold change
ratio of more than ±1.5 between the lean and obese animals
(Figures 3(a) and 3(b)).
In adipose tissue, 37 genes were differentially expressed
between the two groups and 10 of these were significantly
upregulated in obese animals (Figure 3(a), black columns).
Notably, SPP1 (Osteopontin) andCCL5 (RANTES), two cytok-
ines highly expressed in inflammatory states, were overex-
pressed in the adipose tissue of the obese group. In addition,
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LEP (Leptin), a hormone involved in appetite regulation pos-
sessing proinflammatory properties, was increased in obese
pigs. Genes controlling lipid metabolism were also affected:
INSIG1 (insulin induced gene 1), a regulator of choles-
terol homeostasis, ELOVL4 (ELOVL fatty acid elongase 4)
and PECR (peroxisomal trans-2-enoyl-CoA reductase), both
involved in fatty acid metabolism, andDGAT2 (diacylglycerol
O-acyltransferase homolog 2), which is involved in synthesis
and storage of intercellular triglycerides, were upregulated
in obese pigs. SMPDL3A (sphingomyelin phosphodiesterase,
acid-like 3A), involved in cholesterol loading in macrophages
[29], and SLC16A1 (solute carrier family 16), a monocarboxy-
lates transporter, were upregulated in obese pigs.
In PBMCs, a total of 29 genes showedmore than 1.5 log(2)
fold difference between the two groups, but only four
genes were statistically significantly up- or downregulated
(Figure 3(b), black columns). CD40 and FAS (TNF receptor
superfamily members 5 and 6) were both upregulated in the
obese pigs. Both genes are essential for the initiation and pro-
gression of inflammation [30, 31]. TNFAIP3 (tumor necrosis
factor, alpha-induced protein 3) and IL4 (interleukin 4), both
playing a regulatory role in the inflammatory cascade, were
downregulated in the obese animals.
Collectively, our gene expression analyses show dysreg-
ulation of several key genes in both the inflammatory path-
way and fatty acid metabolism, supporting a link between
increased adiposity, impaired lipidmetabolism, and activated
immune response in the adipose tissue.
3.4. Global DNA Methylation Is Altered in Circulating
Leukocytes. An altered epigenetic signature in lymphocytes
and PBMCs has previously been reported in obesity and
metabolic disease [13–15, 32]. Epigenetic modifications in
immune cells could be a mechanism by which the immune
system is deregulated in metabolic disorders. We measured
global DNA methylation levels in circulating PBMCs in
a cell type specific manner (T-helper, T-cytotoxic, double
positive T-cells, natural killer cells and B-cells) using FACS as
previously reported [14]. In obese animals, we found higher
levels of global DNA methylation in lymphocytes but not in
monocytes (Figures 4(a) and 4(b)). The analysis of the indi-
vidual lymphocyte subpopulations showed increased global
DNAmethylation in B-cells (Figures 4(c) and 4(d)), T-helper
cells and T-cytotoxic cells (Figures 4(e) and 4(f)), suggesting
that obesity is associated with altered epigenetic signature in
specific subpopulations of circulating lymphocytes.
4. Discussion
This study aimed at investigating the link between obesity
and altered trafficking and polarisation of immune cells in the
adipose tissue and their potential association with epigenetic
changes in a pig model of obesity. In obese pigs, impaired
glucose tolerance and an altered lipid profile were associated
with increased immune cell infiltration in the visceral adipose
tissue and immune activation. These changes were further
linked to an altered transcriptomic and epigenetic signature
of circulating lymphocytes, which reinforces the concept that
epigenetic processes participate in the increased immune cell
activation and impaired metabolic functions in obesity.
To our knowledge, our study is the first of its kind to
exploit differences in the development of obesity in F2 pigs
produced by breeds that are highly divergent with respect to
obesity, thus ensuring that the obese phenotype is predomi-
nantly genetically determined.
Pigs represent a useful model for obesity research,
although the majority of pig studies have focused on either
different diets or breed differences [25, 33–35]. It is notewor-
thy that our obese animals when compared to the lean ones
had higher total body weight, visceral fat mass, and altered
lipid profile, as well as impaired glucose tolerance. These
results are consistent with previous reports investigating the
effect of high fat diet (HFD) in pigs [25, 33, 36].
Altered infiltration of immune cells in the adipose tissue
of obese pigs has previously been reported in the Ossabaw
pig breed [35]. In this model, the frequency of CD203A+
macrophages was reduced in obese animals receiving a HFD
for 30weeks. In contrast, we report an increased infiltration of
macrophages in obese animals, a finding generally observed
in human andmurine studies [6, 37, 38]. Particularly, the fre-
quency of proinflammatory M1 macrophages was higher in
the adipose tissue from obese pigs, supporting the validity of
ourmodel in recapitulating the specific immune environment
in adipose tissue previously reported in human and murine
obesity [5, 6].
The frequency of T-helper cells was significantly
decreased in the obese pigs. In human and murine obesity
studies, conflicting results have been reported concerning
the frequency of this subpopulation of T-cells [8, 39–41].
Deiuliis et al. (2011) have reported a decrease of total CD4+
T-cells in obese humans, with a concomitant increase in acti-
vated T-effector cells. We did not investigate the specific fre-
quency of the T-helper subpopulations here (effectors versus
regulatory), which could have provided additional informa-
tion, since bothT-effector andT-regulatory cells (Tregs) seem
to play critical roles in insulin resistance and diabetes [40, 42].
The precise sequence of inflammatory cytokine secretion
and immune cell infiltration in the progression of adipose
tissue inflammation is still not fully understood. The most
recent studies have suggested that overnutrition and adipose
tissue expansion cause the adipocytes to secrete various
chemokines and cytokines, which in turnmediate the recruit-
ment and the activation of immune cells to the adipose tissue.
These recruited immune cells then initiate a second wave
of inflammatory chemokine/cytokine production [9]. In our
obese pigs, we found an increase of CCL5 in the adipose tis-
sue, and CCL3L1 and CXCL16 also trended to be upregulated.
This could support increased trafficking of immune cell, as
the upregulation of chemokines is implicated in the overall
recruitment of leukocytes [43]. The upregulation of Leptin
in obese pigs could also have contributed to the increase in
immune cells trafficking to the adipose tissue since it has been
shown to stimulate innate immune response by increasing
chemotaxis and enhancing the secretion of proinflammatory
cytokines [44]. Similarly, the upregulation of SPP1 underpins
an increased infiltration of immune cells and the resulting
inflammatory process, as this gene is highly induced during
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Figure 4: Global DNA methylation in PBMCs subpopulations from lean (grey columns and histograms) and obese pigs (open columns
and histograms). (a) Representative quantification of 5-methylcytosine levels in lymphocytes and monocytes. (b) Quantification of 5-
methylcytosine levels (MFI) in lymphocytes andmonocytes. (c) Representative quantification of 5-methylcytosine levels in T-cells (CD3+), B-
cells (CD21+), and natural killer cells (NKp46+). (d) Quantification of 5-methylcytosine levels (MFI) in T-cells, B-cells, and natural killer cells.
(e) Representative quantification of 5-methylcytosine levels in T-cells subpopulations: T-helper (CD3+CD4+), T-cytotoxic (CD3+CD8+), and
double positive T-cells (CD3+CD4+CD8+). (f) Quantification of 5-methylcytosine levels (MFI) in T-helper, T-cytotoxic, and double positive
T-cells. Data are mean ± SD. ∗𝑝 < 0.05. MFI: median fluorescence intensity.
inflammation in obesity [45]. A further evidence for immune
activation is that interleukins IL1B, IL6, IL8, and IL18 and
the Toll-like receptors TLR2 and TLR4 also tended to be
upregulated in the obese animals.
The decreased frequency of circulating monocytes in
obese animals could also suggest thatmonocytes are recruited
to the adipose tissue of obese animals. This is consistent with
previous findings in high fat-fed mice, where a significant
decrease of the peripheral monocyte population was
observed, concomitant with an increased macrophage infil-
tration in adipose tissue [46]. We also found an increased
number of B-cells in the blood stream of the obese pigs. This
could be consistent with systemic immune activation as
previously described [7]. Upregulation of CD40 and FAS in
PBMCs fromobese pigsmight reflect the increased frequency
of circulating B-cells. Both CD40 and FAS have recently been
shown to be increased in plasma from obese subjects and are
highly expressed by B-cells [31, 47]. It can be speculated that
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the upregulation of these two proteins could be an indication
of a proinflammatory environment in obese pigs, as both
genes are associated with the regulation of immune response
[47, 48]. In contrast, TNFAIP3, one of the key inhibitors of
the nuclear factor-kB family, which plays a critical role in
the regulation of inflammation, was downregulated in the
obese group. In vivo gene targeting studies have established
its importance in the regulation of inflammation in myeloid
cells, B-cells, and macrophages that lack TNFAIP3 [49, 50].
Similarly, the anti-inflammatory cytokine IL4was also down-
regulated in obese pigs, contributing to the proinflammatory
environment and increased lipid accumulation [51].
The pigs used in this study were born at the same time
of the year and housed in the same building under the same
environmental conditions with free access to food and water,
and none of them suffered from diseases that needed antibi-
otics/treatments during their lifespan.This very stringent and
controlled environment suggests that the differences in epige-
netic profile we report in these pigs are most likely to reflect
variations due to obesity. Epigenetic regulation of immune
cells has previously been associated with changes in cytokine
production and could thereby influence the inflammatory
environment associated with obesity [52]. The global DNA
methylation profile of circulating immune cells was therefore
established using flow cytometry allowing us to detect differ-
ences in specific subpopulations of PBMCs. We observed a
global DNA hypermethylation in B-cells and T-helper and
T-cytotoxic cells, consistent with our recent findings in B-
cells from obese individuals [14]. In this previous study,
hypermethylation in B- and NK-cells was associated with the
severity of insulin resistance. We failed to observe such
relation in our animals, which could be explained by the fact
that these pigs had not yet developed a severe level of insulin
resistance. It is noteworthy that we observed an increased
globalDNAmethylation inT-helper, T-cytotoxic, andB-cells,
since these cells not only have been linked to the development
of obesity but also have been suggested to be part of the
initiation andmaintenance of inflammation in adipose tissue,
contributing to the recruitment of macrophages and the
development of insulin resistance [7, 8, 41, 53].
In summary, we have established a porcine model of obe-
sity, which displays numerous characteristics of the human
metabolic syndrome. We show that obese pigs are charac-
terised by early defects in glucose metabolism and increased
recruitment of monocytes/macrophages to the adipose tissue
and exhibit a proinflammatory environment in both adipose
tissue and peripheral blood. The altered epigenetic profile
we detect in lymphocytes is likely to contribute to the
proinflammatory environment and could therefore represent
an early marker of immune cell recruitment and activation in
obesity.
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